RNA Therapeutics Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024-2031)
RNA-Therapeutics Market wird nach Art der Modalität (RNA-Therapeutik, RNA-Impfstoffe), nach Art der Moleküle (Replicating RNA (repRNA), Selbstverstärkende RNA (saRNA), Selbstaktivierende RNA (sacRNA), Selbstaktivierende mRNA (samRNA), Transfer RNA (tRNA) segmentiert. Der Bericht bietet den Wert (in Mio. USD) für die genannten Segmente.
Competitive overview of RNA Therapeutics Market
Zu den wichtigsten Spielern im RNA-Therapeutikmarkt gehören Alphavax, Arcturus Therapeutics, Atyr Pharma, Gritstone Bio, HDT Bio, Laronde Therapeutics, MiNA Therapeutics, Orna Therapeutics, Recode Therapeutics, Renegade Therapeutics, Replicate Bioscience, Shape Therapeutics und VLP Therapeutics
RNA Therapeutics Market Leaders
- Alphavax
- Arcturus Therapeuten
- Atyr Pharma
- Gridstone Bio
- HDT Bio
*Disclaimer: Major players are listed in no particular order.
RNA Therapeutics Market - Competitive Rivalry, 2023
RNA Therapeutics Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights